Drugmakers face weaker won

It is a challenging time for leading domestic pharmaceutical firms – Dong-A Pharm, Yuhan Corporation and Daewoong Pharm - to cope with the won's weakness against major currencies.

“The hike of raw material prices and the fall in the value of the Korean currency eroded the revenues of these companies in the first half of this year despite their overall sales growth,” said Shin Ji-won, an anal...